Public Employees Retirement Association of Colorado
AKRO

Public Employees Retirement Association of Colorado’s Akero Therapeutics AKRO Stock Holding History

Public Employees Retirement Association of Colorado’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,148
Closed -$387K – 1865
2025
Q3 		$387K Hold
8,148
– – ﹤0.01% 1107
2025
Q2 		$435K Buy
+8,148
New +$370K ﹤0.01% 1038

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Public Employees Retirement Association of Colorado's AKRO Position: Q4 2025 in Review

Public Employees Retirement Association of Colorado sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 8,148 shares — an estimated $387K sold.

Public Employees Retirement Association of Colorado first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $435K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Public Employees Retirement Association of Colorado reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 8,148 Akero Therapeutics shares in Q4 2025, an estimated $387K.
  • Public Employees Retirement Association of Colorado first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
  • Public Employees Retirement Association of Colorado's Akero Therapeutics position peaked at $435K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q4 2025, filed 13 Feb 2026.